These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 19521331)

  • 1. Etiology and management of tumor lysis syndrome in patients with chronic lymphocytic leukemia.
    Cheson BD
    Clin Adv Hematol Oncol; 2009 Apr; 7(4):263-71. PubMed ID: 19521331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor lysis syndrome (TLS) following fludarabine therapy for chronic lymphocytic leukemia (CLL): case report and review of the literature.
    Hussain K; Mazza JJ; Clouse LH
    Am J Hematol; 2003 Mar; 72(3):212-5. PubMed ID: 12605395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An integrated clinical approach for the identification, prevention, and treatment of tumor lysis syndrome.
    Mughal TI; Ejaz AA; Foringer JR; Coiffier B
    Cancer Treat Rev; 2010 Apr; 36(2):164-76. PubMed ID: 20031331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review.
    Coiffier B; Altman A; Pui CH; Younes A; Cairo MS
    J Clin Oncol; 2008 Jun; 26(16):2767-78. PubMed ID: 18509186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute tumor lysis syndrome during oral fludarabine treatment for CLL--a rare event that might be observed more frequently in the future.
    Rioufol C; Coiffier B
    Onkologie; 2008 Apr; 31(4):157-8. PubMed ID: 18418014
    [No Abstract]   [Full Text] [Related]  

  • 6. A review of pharmacologic options for previously untreated chronic lymphocytic leukemia.
    Wilhelm K; Yang D
    J Oncol Pharm Pract; 2011 Jun; 17(2):91-103. PubMed ID: 20085962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor Lysis Syndrome in Chronic Lymphocytic Leukemia with Novel Targeted Agents.
    Cheson BD; Heitner Enschede S; Cerri E; Desai M; Potluri J; Lamanna N; Tam C
    Oncologist; 2017 Nov; 22(11):1283-1291. PubMed ID: 28851760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent chemotherapy-induced tumor lysis syndrome (TLS) with renal failure in a patient with chronic lymphocytic leukemia - successful treatment and prevention of TLS with low-dose rasburicase.
    Hummel M; Buchheidt D; Reiter S; Bergmann J; Adam K; Hehlmann R
    Eur J Haematol; 2005 Dec; 75(6):518-21. PubMed ID: 16313266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent progress in the management of chronic lymphocytic leukemia.
    Robak T
    Cancer Treat Rev; 2007 Dec; 33(8):710-28. PubMed ID: 17904294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tumor lysis syndrome. A life-threatening complication during cytostatic treatment of chemosensitive types of cancer].
    Wibe E; Kvaløy S; Nome O; Abrahamsen AF; Bjørgo S
    Tidsskr Nor Laegeforen; 1991 Aug; 111(19):2435-7. PubMed ID: 1926084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor lysis syndrome/tumor flare reaction in lenalidomide-treated chronic lymphocytic leukemia.
    Moutouh-de Parseval LA; Weiss L; DeLap RJ; Knight RD; Zeldis JB
    J Clin Oncol; 2007 Nov; 25(31):5047. PubMed ID: 17971612
    [No Abstract]   [Full Text] [Related]  

  • 12. Tumor lysis syndrome occurring after the administration of rituximab for posttransplant lymphoproliferative disorder.
    Francescone SA; Murphy B; Fallon JT; Hammond K; Pinney S
    Transplant Proc; 2009 Jun; 41(5):1946-8. PubMed ID: 19545762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor lysis syndrome following chlorambucil therapy for chronic lymphocytic leukemia: case report and review of the literature.
    Kosseifi SG; Vyas B; Vyas H; Krishnaswamy G; Smith S
    Tenn Med; 2009 Oct; 102(10):33-6. PubMed ID: 19899317
    [No Abstract]   [Full Text] [Related]  

  • 14. Bendamustine in the treatment of chronic lymphocytic leukemia.
    Knauf W
    Expert Rev Anticancer Ther; 2009 Feb; 9(2):165-74. PubMed ID: 19192955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor lysis syndrome associated with fludarabine treatment in chronic lymphocytic leukemia.
    Dizdar O; Yürekli BS; Pürnak T; Aksu S; Haznedaroglu IC
    Ann Pharmacother; 2004; 38(7-8):1319-20. PubMed ID: 15138295
    [No Abstract]   [Full Text] [Related]  

  • 16. Tumor lysis syndrome occurring after the administration of rituximab in lymphoproliferative disorders: high-grade non-Hodgkin's lymphoma and chronic lymphocytic leukemia.
    Yang H; Rosove MH; Figlin RA
    Am J Hematol; 1999 Dec; 62(4):247-50. PubMed ID: 10589082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of patients with chronic lymphocytic leukemia treated with lenalidomide.
    Miller KC; Musial L; Whitworth A; Chanan-Khan A
    Clin J Oncol Nurs; 2010 Aug; 14(4):491-9. PubMed ID: 20682505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor lysis syndrome and acute kidney injury: evaluation, prevention, and management.
    Abu-Alfa AK; Younes A
    Am J Kidney Dis; 2010 May; 55(5 Suppl 3):S1-13; quiz S14-9. PubMed ID: 20420966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nursing guidelines for managing infections in patients with chronic lymphocytic leukemia.
    Moran M; Browning M; Buckby E
    Clin J Oncol Nurs; 2007 Dec; 11(6):914-24. PubMed ID: 18063549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor lysis syndrome: an uncommon complication of fludarabine therapy of chronic lymphocytic leukemia.
    Cheson BD; Frame JN; Vena D; Quashu N; Sorensen JM
    J Clin Oncol; 1998 Jul; 16(7):2313-20. PubMed ID: 9667245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.